1. Home
  2. LGVN vs BREA Comparison

LGVN vs BREA Comparison

Compare LGVN & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • LGVN
  • BREA
  • Stock Information
  • Founded
  • LGVN 2014
  • BREA 2022
  • Country
  • LGVN United States
  • BREA Ireland
  • Employees
  • LGVN N/A
  • BREA N/A
  • Industry
  • LGVN Medicinal Chemicals and Botanical Products
  • BREA Services-Misc. Amusement & Recreation
  • Sector
  • LGVN Health Care
  • BREA Consumer Discretionary
  • Exchange
  • LGVN Nasdaq
  • BREA Nasdaq
  • Market Cap
  • LGVN 7.8M
  • BREA 9.9M
  • IPO Year
  • LGVN 2021
  • BREA 2023
  • Fundamental
  • Price
  • LGVN $4.39
  • BREA $0.72
  • Analyst Decision
  • LGVN Strong Buy
  • BREA
  • Analyst Count
  • LGVN 1
  • BREA 0
  • Target Price
  • LGVN $12.00
  • BREA N/A
  • AVG Volume (30 Days)
  • LGVN 24.4M
  • BREA 20.3K
  • Earning Date
  • LGVN 08-09-2024
  • BREA 07-23-2024
  • Dividend Yield
  • LGVN N/A
  • BREA N/A
  • EPS Growth
  • LGVN N/A
  • BREA N/A
  • EPS
  • LGVN N/A
  • BREA N/A
  • Revenue
  • LGVN $978,000.00
  • BREA $120,788.00
  • Revenue This Year
  • LGVN $137.24
  • BREA N/A
  • Revenue Next Year
  • LGVN $50.77
  • BREA N/A
  • P/E Ratio
  • LGVN N/A
  • BREA N/A
  • Revenue Growth
  • LGVN N/A
  • BREA N/A
  • 52 Week Low
  • LGVN $0.77
  • BREA $0.53
  • 52 Week High
  • LGVN $37.50
  • BREA $3.00
  • Technical
  • Relative Strength Index (RSI)
  • LGVN 71.83
  • BREA 35.49
  • Support Level
  • LGVN $3.80
  • BREA $0.66
  • Resistance Level
  • LGVN $6.40
  • BREA $0.80
  • Average True Range (ATR)
  • LGVN 0.53
  • BREA 0.07
  • MACD
  • LGVN 0.28
  • BREA 0.00
  • Stochastic Oscillator
  • LGVN 59.31
  • BREA 30.77

About LGVN Longeveron Inc.

Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.

About BREA Brera Holdings PLC

Brera Holdings PLC focused on expanding social impact football by developing a global portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.

Share on Social Networks: